| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.15 | 0.0006 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |